Unicycive Therapeutics, Inc. · NASDAQ:UNCY
BVF PARTNERS L P/IL reported a 9.99% stake in Unicycive Therapeutics, Inc. (Schedule 13G/A)
Event Jun 30, 2025 · Filed Aug 14, 2025
BVF PARTNERS L P/IL reported a 9.99% stake in Unicycive Therapeutics, Inc., 1,417,117 shares, as a passive investor on Jun 30, 2025. Filed Aug 14, 2025 (Schedule 13G/A).
- Stake
- 9.99%
- Shares
- 1,417,117
- Intent
- Passive
- What changed
- Stake changed
- Filed together
- 10 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| BIOTECHNOLOGY VALUE FUND L P | 5.70% | 777,308 |
| BVF I GP LLC | 5.70% | 777,308 |
| BIOTECHNOLOGY VALUE FUND II LP | 4.40% | 591,650 |
| BVF II GP LLC | 4.40% | 591,650 |
| Biotechnology Value Trading Fund OS LP | 0.30% | 35,480 |
| BVF Partners OS Ltd. | 0.30% | 35,480 |
| BVF GP HOLDINGS LLC | 9.70% | 1,368,958 |
| BVF PARTNERS L P/IL | 9.99% | 1,417,117 |
| BVF INC/IL | 9.99% | 1,417,117 |
| LAMPERT MARK N | 9.99% | 1,417,117 |
Source
Related
- Unicycive Therapeutics, Inc.
- Bvf Partners L P
- Unicycive Therapeutics, Inc. shareholders
- Schedule 13G/A · Nantahala Capital Management, LLC · Aug 14, 2026
- Schedule 13G/A · Vivo Opportunity, LLC · Aug 14, 2026
- Schedule 13G · BlackRock, Inc. · Jul 30, 2026
- Schedule 13G/A · Millennium Management LLC · Jul 8, 2026
- Schedule 13G/A · Ra Capital Management, L.P. · May 15, 2026